21 CFR 50.50
§ 50.50 IRB duties.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 50.50, § 50.50 IRB duties, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/83457
- Permanent ID
ys:prov:83457@1- SHA-256
456bc988c6d2220318e2b2d128587ef6a24fab3f7e41356ab7bfa61c07c00ba9
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
In addition to other responsibilities assigned to IRBs under this part and part 56 of this chapter, each IRB must review clinical investigations involving children as subjects covered by this subpart D and approve only those clinical investigations that satisfy the criteria described in § 50.51, § 50.52, or § 50.53 and the conditions of all other applicable sections of this subpart D.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.